Company intelligence / Profile preview
TWi Biotechnology, Inc.
Taipei, Taipei City, Taiwantwibiotech.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
TWi Biotechnology is a clinical-stage biopharmaceutical company focused on developing repositioned small molecule drugs for rare diseases associated with inflammation. Its lead asset, diacerein (AC‑203), is in global Phase III trials for epidermolysis bullosa. Other programs include topical tofacitinib citrate for granuloma annulare and vitiligo in early clinical development. The company has demonstrated positive safety and efficacy signals in rare dermatological indications.
- Therapeutic areas
- DermatologyRheumatologyEndocrinology
- Modalities
- Small molecules (notably diacerein and tofacitinib citrate)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Castle Creek Pharmaceuticals LLC – exclusive license/development/commercialization agreement for AC‑203 outside Asia/Australia/NZHong Kong Winhealth Pharma Group Co., Limited – drug development agreement covering Mainland China/Hong Kong/Macao markets
Beyond the preview
Go deeper on TWi Biotechnology, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TWi Biotechnology, Inc..